System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Muhamed-Kheir Taha is an expert in Infectiology at GHU AP-HP.Centre - Université Paris Cité (France). Muhamed-Kheir Taha has authored 359 publications, the most recent in 2026, and is an investigator in 6 clinical trials, 1 of them ongoing. SLR score: 1,319 (community average: 125). How the SLR is computed.

LeadR Profile

Muhamed-Kheir Taha GHU AP-HP.Centre - Université Paris Cité France
1 319 ScienceLeadR Reputation 1319

Unlock

Register Login
Network Map

Infectiology

Subspecialties: Immunology - Public Health - Pediatrics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1988 - 2026
Source: PubMed

Institut Pasteur

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 359

Citations

Citations: 12 649 1st author: 48 Last author: 117 Unique author: 6

Main journals

Vaccine 20
J Infect 19
Hum Vaccin Immunother 13
Euro Surveill 10
J Clin Microbiol 10

Best Journals

Lancet Digit Health 1
Lancet Infect Dis 1
N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
A multinational genomic framework for predicting β-lactam resistance in Haemophilus influenzae.
PMID 42747902 — genes, classification, drug therapy, haemophilus, haemophilus influenzae, alleles, vocabulary, lactams		J Antimicrob Chemother20260
Abdominal symptoms of invasive meningococcal disease are associated with the induction of plasminogen activator inhibitor-1 in omental adipocytes.
PMID 42469670 — plasminogen activator inhibitor 1, genes, plasminogen inactivators, plasminogen, meningococcal infections, plasminogen activators, adipocytes, signs and symptoms, communicable diseases		BMC Infect Dis20261
Role of biofilm formation and antimicrobial resistance in urogenital Haemophilus influenzae isolates.
PMID 41808008 — genes, ciprofloxacin, ampicillin, amoxicillin, genome, microbiology, haemophilus, biofilms, haemophilus influenzae, trimethoprim, sulfamethoxazole drug combination, cephalosporins, placenta, infections		BMC Microbiol20260
Carriage of Haemophilus influenzae in the Pre- and Post-Hib Vaccine Eras Revisited: A Systematic Review and Meta-Analysis.
PMID 42347663 — vaccines, haemophilus influenzae type b, haemophilus, vaccination, haemophilus influenzae, carrier state, prevalence		Vaccines (Basel)20260
Resurgence of invasive Haemophilus influenzae type b disease in France, 2017-2024: epidemiological, genomic, and immunological insights.
PMID 42129179 — complement c3b, vaccines, haemophilus influenzae type b, haemophilus, vaccination, haemophilus influenzae, complement system proteins, child		NPJ Vaccines20260

Clinical Studies 6

Sources: ClinicalTrials, EU CTIS

Synthesis

Study Director: 1

By phase:

N/A 4
Phase 3 2

By status:

Completed 3
Recruiting 2
Terminated 1

By type:

Interventional 3
Observational 3

By Monocentric/Multicentric:

monocentric 4
multicentric2to4 0
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Research Trial Assessing the Immunogenicity and Safety of Three Meningococcal B Vaccine Strategies Among Patients With Asplenia
NCT04166656 — injections, safety, vaccines, suspensions, syringes, research, injections, intramuscular, splenectomy		Phase 3Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS